Introduction Measles, mumps, and rubella incidence decreased drastically following
vaccination programs' implementation. However, measles and mumps' resurgence was …

Background Rubella containing vaccines (RCV) prevent rubella virus infection and
subsequent congenital rubella syndrome (CRS). To update the evidence on …

New vaccines designed to prevent diseases endemic in low and middle-income countries
(LMICs) are now being introduced without prior record of utilization in countries with robust …

It has long been known that oncolytic viruses wield their therapeutic capability by priming an
inflammatory state within the tumor and activating the tumor immune microenvironment …

Mumps is a vaccine-preventable disease. Because the mumps vaccine can cause aseptic
meningitis in rare cases, this vaccine is not routine in Japan. This has led to low vaccine …

Justification In view of new developments in vaccinology and the availability of new
vaccines, there is a need to revise/review the existing immunization recommendations …

Measles, mumps, and rubella (MMR) are highly infectious viral diseases affecting young
children and have high secondary attack rates. Present MMR vaccines show consistent …

In recent years, the application of vaccines shows limitations, including the high number of
vaccine administrations and the fear of safety and effectiveness. In this regard, advanced …

Background: As a part of a measles and rubella (MR) campaign, the MR vaccine replaced
the two-dose measles vaccine at 9–12 months and 16–24 months of age under the …

The MMR vaccine as we know is a vital vaccine to protect against three disease-causing
microbes-measles, mumps, and rubella. To commemorate 75 years of Indian independence …